Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GlaxoSmithKline's gepotidacin shows potential against anthrax

Feb. 9, 2016

Peptide-based antigen-specific immunotherapy prevents anti-FVIII responses

Feb. 9, 2016

Long-acting FVIIa shows promise for the treatment of hemophilia

Feb. 8, 2016

Recombinant factor VIII exhibits promising profile for the treatment of hemophilia A

Feb. 8, 2016

Biochemical and PK characterization of BAX-826

Feb. 5, 2016

DKN-01 plus paclitaxel well tolerated in patients with EC or GEJ

Jan. 29, 2016

Urine-exosome signature validated in prostate cancer patients

Jan. 28, 2016

Supinoxin demonstrates preclinical efficacy to treat renal cancer

Jan. 28, 2016

BBI-608 plus paclitaxel shows promise for the treatment of refractory pancreatic cancer

Jan. 27, 2016

Tissue-engineered cartilage shows promise for laryngotracheal reconstruction

Jan. 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026